Feline immunodeficiency virus (FIV), as well as feline leukemia virus, is thought to be associated with feline AIDS (18, 27) . The lymphocyte-proliferative response to mitogens is decreased at all stages in FIV infection (23) , and selective depletion of the CD4+ lymphocyte subset has been observed in experimentally infected specific-pathogen-free cats (1, 25) . Recently, we reported that peripheral blood mononuclear cells from cats naturally infected with FIV were activated in vivo and that these cells were unresponsive to further stimuli in vitro (17) .
Tumor necrosis factor alpha (TNF-a), also known as cachectin, is likely to play an important role in human immunodeficiency virus (HIV) infection. The serum level of TNF-ot is increased in AIDS patients (12) , and peripheral blood monocytes from HIV-infected patients spontaneously secrete more TNF-cx than do monocytes isolated from uninfected individuals (13) . TNF-a has been reported to activate replication of HIV in chronically infected cells (5, 15, 20) , as do other factors such as interleukin-6 (19) , granulocytemacrophage colony-stimulating factor (10) , and phorbol 12-myristate 13-acetate (5, 8, 20) . Furthermore, TNF-a was found to have a direct cytocidal effect on chronically HIV-infected cells but not on uninfected cells in vitro (15) . However the mechanism by which TNF-a exerts its cytotoxic effect on HIV-infected cells is not yet fully defined.
In this study, we demonstrated that recombinant human TNF-ot induced programmed cell death (apoptosis) in cells chronically infected with FIV. The results reported here may provide useful information for understanding the pathogenesis of FIV infection.
MATERIALS AND METHODS
Cells and cell culture. The feline fibroblastic cell line CRFK was used as an uninfected control (2) . CRFK cells chronically infected with a Petaluma strain of FIV (CRFK/ FIV) (27) were kindly provided by T. Ishida, Nippon Veter-* Corresponding author. inary and Animal Science University. These cells were maintained in RPMI 1640 containing gentamicin (20 ,ug/ml), L-glutamine (2 mM), and 10% heat-inactivated fetal calf serum. Both of these adherent cell lines were passaged with use of trypsin (0.05%) and EDTA (0.02%).
Cytokines. Human recombinant TNF-a and anti-TNF-ct monoclonal antibody were obtained from Suntory Institute for Biochemical Research (Osaka, Japan). The purity of recombinant TNF-a (98.6%) was estimated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. The specific activity, confirmed by using L929 cells, was 
RESULTS
Effects of TNF-a on FIV replication. For examination of the effect of TNF-a on replication of FIV, CRFK/FIV cells were cultured in the presence or absence of TNF-a for 12 h, and then the RT activity of the culture supernatant was determined. As shown in Fig. 1A , TNF-a suppressed FIV replication in a dose-dependent manner. Treatment with 100 U of TNF-a per ml induced 70% reduction in RT activity in CRFK/FIV cells. The suppression of FIV production was blocked by anti-TNF-a antibody (Fig. 1B) , indicating that other impurities could be excluded in this experiment.
Morphologic change of CRFK/FIV cells cultured with TNF-a. As shown in Fig. 2A , after culture with TNF-a (100 U/ml) for 6 h, CRFK/FIV cells showed morphologic changes such as cell shrinkage and detachment from the culture flasks, whereas uninfected CRFK cells showed no morphologic changes. In the Giemsa-stained preparations, cell shrinkage and condensation of chromatin were apparent in most of these CRFK/FIV cells cultured with TNF-a (Fig.  2B) . Transmission electron micrographs of TNF-a-treated CRFK/FIV cells also showed condensation of chromatin and cytoplasm together with disappearance of surface microvilli and enlargement of the endoplasmic reticulum (Fig. 2C) , changes which are characteristics of apoptosis.
Cytocidal effect of TNF-a on CRFK/FIV cells. To determine the cytotoxic activity of TNF on these cells, we examined the viability of CRFK/FIV cells after treatment with TNF-ct. The initial number of cells was adjusted to 2 x 105/ml, and the cells were cultured for 12 h. TNF-ot (1, 10, and 100 U/ml) was then added, and the viability of the cells was scored after 0, 24, 48, and 72 h of culture. As shown in Fig. 3 , in the presence of 10 or 100 U of TNF-a per ml, the viability of CRFK/FIV cells markedly decreased after 48 h, whereas that of uninfected CRFK cells remained unchanged.
After culture with TNF-a (100 U/ml) for 72 h, the viabilities of uninfected CRFK and CRFK/FIV cells were 84 and 19%, respectively. In the presence of TNF-a, the viability of CRFK/FIV cells did not change within 24 h of culture despite their morphologic changes. 
DISCUSSION
A major immunologic abnormality in AIDS is considered to be selective depletion of CD4+ lymphocytes (4) . HIV has a selective tropism for CD4+ cells, and active replication of virus usually induces host cell death (14 cation (5, 15, 20) and to kill HIV-infected cells (15) , suggesting that TNF-a plays an important role in the pathogenesis of AIDS.
In this study, TNF-a was found to destroy CRFK/FIV cells but not uninfected CRFK cells. This result is consistent with the observation that TNF-a has a cytocidal effect on cells chronically infected with HIV (15) . TNF-a-induced morphologic changes of CRFK/FIV cells were detected as early as within 3 h of cultures. The viability of these cells showing cell shrinkage and chromatin condensation did not alter within 24 h of culture, as judged by the trypan blue dye exclusion test. However, further cultivation with TNF-a caused cell death (after 48 h of culture). The cytopathic changes observed in TNF-ot-treated CRFKIFIV cells were similar to those observed during programmed cell death (apoptosis) (22) . Apoptosis is an active suicide process in which an endogenous endonuclease cuts DNA in nucleosomal linker regions while the cells are still viable. Some investigators have reported that TNF-at kills certain cell lines by apoptosis (11, 21) . Moreover, by a DNA fragmentation assay, we found that DNA extracted from TNF-a-treated CRFKIFIV cells showed a ladder of nucleosomal DNA, strongly suggesting that TNF-ot induced apoptosis of CRFK/ FIV cells. Apoptosis-mediated cell death has also been observed in the ligation of CD4 before signaling through the T-cell receptor (16) and acute HIV-1 infection (24) . Therefore, apoptosis may account at least in part for the cytopathic effects in FIV infection as well as in HIV infection.
It is not clear how TNF-a selectively destroys FIVinfected cells by apoptosis without affecting uninfected cells. In preliminary experiments, we found that uninfected CRFK cells became sensitive to TNF-a cyotoxicity upon treatment with actinomycin D, suggesting the existence of a TNF-a receptor on both uninfected CRFK cells and CRFK/FIV cells. Recent findings indicate that several cellular genes such as bcl-2 (9) , p53 (28) , and c-myc (3) are associated with programmed cell death, suggesting that the sensitivity to In this study, in contrast to the accumulated findings observed in HIV-infected cell lines (5, 15, 20) , recombinant human TNF-cx suppressed viral replication in CRFK/FIV cells in a dose-dependent manner. Although the mechanism of the suppression of FIV replication is not clear, the programmed cell death that occurred in TNF-ao-treated CRFK/FIV cells may be associated with this phenomenon. Recently, Wong et al. (26) reported that TNF-a and gamma interferon exerted synergistic blockade on the replication of HIV and killed HIV-infected cells. It might be also necessary to examine whether gamma interferon participates in the suppression of FIV replication by TNF-a.
TNF-ao is one of the earliest products by the host response to many infections (6), so its induction by other viral or bacterial infections is likely to induce programmed cell death in FIV-infected cells. Thus, it is highly conceivable that TNF-a is associated with the pathogenesis of the immunodeficiency-like syndrome in FIV infection through the induction of apoptosis in the virus-infected cells. These findings may also have implications for the design of specific therapeutic strategies for AIDS in humans as well as cats. 
